Monique Kosse | Investor Relations |
T. J. Johnson | Chief Executive Officer |
Shaun McMeans | Chief Financial Officer |
Mark Massaro | Canaccord Genuity |
Julian Harrison | H.C. Wainwright |
Puneet Souda | Leerink Partners |
Good day, and welcome to today’s HTG Molecular Diagnostics’ Second Quarter 2018 Earnings Call. I would like to remind everyone this conference is being recorded. And now I would like to turn the floor over to Monique Kosse. Please go ahead.
Thank you, Greg.